Article Details

Freenome nabs $160M to advance blood-based colorectal cancer test

Retrieved on: 2019-07-24 05:17:02

Tags for this article:

Click the tags to see associated articles and topics

Freenome nabs $160M to advance blood-based colorectal cancer test. View article details on hiswai:

Excerpt

<div>... <b>Polaris Partners</b> to launch its pivotal trial for its blood-based test to screen for colorectal cancer. <b>Polaris Partners</b> and RA Capital will join Freenome's ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up